Article
miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1
1 Nov 2016
Abstract excerpt
Drug resistance remains a major unresolved obstacle for gastric cancer (GC) treatment. Recently, increasing studies have showen that microRNAs (miRNAs) are involved in cancer chemotherapeutic resistance and can potentially be applied to reverse drug resistance in cancers. The relationship between miRNA-149 expression and cisplatin (DDP) resistance in GC cells is still unknown. Here, we detected miR-149 expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
